BModesto offers a growing portfolio of specialty medicines for the Dutch hospital sector.
With a recent registration in the field of urological oncology care, we have further expanded our portfolio and strengthened our contribution to specialist oncology treatments.
This expansion aligns with BModesto’s strategic focus on ensuring the availability and continuity of medicines for complex hospital treatments. Through close collaboration with healthcare professionals, we support access to high-quality care for patients with urological oncological conditions.
Information for healthcare professionals
This page contains only brand names, the associated active substances at a high level of abstraction, product characteristics, and package leaflets.
| Product | Active substance | Therapeutic domain | Downloads |
| Cyress 10 mg | Barnidipine | Cardiovasculaire care | Patiëntenbijsluiter Cyress barnidipine 10mg Productkenmerken Cyress barnidipine 10mg |
| Cyress 20 mg | Barnidipine | Cardiovasculaire care | Patiëntenbijsluiter Cyress barnidipine 20mg Productkenmerken Cyress barnidipine 20mg |
| BM Onco BCG | Bacillus Calmette-Guérin (BCG) | Oncology care | Productkenmerken BM Onco BCG Verkorte productinformatie Q&A |
(The active substances are included solely for identification purposes and do not constitute medical or treatment-related information).